Understanding how multiple chronic diseases affect adults over time
Disparities in the burden and progression of multi-morbidity across adulthood
This study is looking at how multiple long-term health conditions, like diabetes and heart disease, affect adults starting at age 30, especially in different racial and ethnic groups, to find better ways to help those who are dealing with these issues.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11079552 on NIH RePORTER |
What this research studies
This research investigates the burden and progression of multiple chronic diseases, known as multimorbidity, among adults starting at age 30. By analyzing data from several national health studies, the project aims to identify how these diseases develop and progress differently across various population groups, particularly focusing on racial and ethnic minorities. The researchers will track the incidence of chronic diseases and develop guidelines to improve clinical practices and interventions for those affected. This comprehensive approach will help in understanding the timing and risk factors associated with multimorbidity.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults aged 30 and older, particularly those from racial and ethnic minority groups who may experience higher rates of multimorbidity.
Not a fit: Patients under the age of 30 or those without chronic diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved clinical guidelines and interventions that better address the needs of patients with multiple chronic conditions.
How similar studies have performed: Previous research has shown success in understanding chronic diseases through longitudinal studies, indicating that this approach is promising and builds on established methodologies.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Argeseanu Cunningham, Solveig — Emory University
- Study coordinator: Argeseanu Cunningham, Solveig
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.